# Durata Therapeutics

**Canonical:** https://apis.io/providers/durata-therapeutics/  
**APIs profiled:** 0

Durata Therapeutics was a clinical-stage pharmaceutical company founded in 2009 around anti-infective assets acquired from Pfizer's Vicuron division, headquartered first in Morristown, New Jersey and from 2012 in Chicago, Illinois. Its lead candidate was dalbavancin, a long-acting semisynthetic lipoglycopeptide antibiotic taken into Phase III trials from 2011 for acute bacterial skin and skin-structure infections and later marketed as Dalvance. The company was backed by Canaan Partners and was acquired by Actavis (now Allergan) on November 17, 2014 for approximately $675 million, at which point it ceased to operate as an independent entity. Durata Therapeutics published no developer program, no public API, and no machine-readable API artifacts; its corporate domain duratatherapeutics.com no longer resolves. This profile is retained as a historical company record in the API Evangelist network.

## Kin Score — 2.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 2.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Pharmaceuticals, Biotechnology, Life Sciences, Health, Anti-Infectives, Drug Development, Acquired, Defunct

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/durata-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.
